125 related articles for article (PubMed ID: 690779)
1. Pharmacokinetic disposition and protein binding of furosemide in newborn infants.
Aranda JV; Perez J; Sitar DS; Collinage J; Portuguez-Malavasi A; Duffy B; Dupont C
J Pediatr; 1978 Sep; 93(3):507-11. PubMed ID: 690779
[TBL] [Abstract][Full Text] [Related]
2. Plasma and urinary kinetics of furosemide in newborn infants.
Tuck S; Morselli P; Broquaire M; Vert P
J Pediatr; 1983 Sep; 103(3):481-5. PubMed ID: 6886918
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of furosemide in the premature newborn infant.
Peterson RG; Simmons MA; Rumack BH; Levine RL; Brooks JG
J Pediatr; 1980 Jul; 97(1):139-43. PubMed ID: 7381633
[TBL] [Abstract][Full Text] [Related]
4. Furosemide disposition in cirrhosis.
Verbeeck RK; Patwardhan RV; Villeneuve JP; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1982 Jun; 31(6):719-25. PubMed ID: 7075120
[TBL] [Abstract][Full Text] [Related]
5. The displacement of bilirubin from albumin by furosemide.
Shankaran S; Poland RL
J Pediatr; 1977 Apr; 90(4):642-6. PubMed ID: 839387
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of furosemide in neonates.
Vert P; Broquaire M; Legagneur M; Morselli PL
Eur J Clin Pharmacol; 1982; 22(1):39-45. PubMed ID: 7094973
[TBL] [Abstract][Full Text] [Related]
7. Elimination of furosemide in healthy subjects and in those with renal failure.
Beermann B; Dalén E; Lindström B
Clin Pharmacol Ther; 1977 Jul; 22(1):70-8. PubMed ID: 872498
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of diuretics and methylxanthines in the neonate.
Aranda JV; Turmen T; Sasyniuk BI
Eur J Clin Pharmacol; 1980 Jul; 18(1):55-63. PubMed ID: 7398749
[TBL] [Abstract][Full Text] [Related]
9. Furosemide disposition in cirrhotic patients.
Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
[TBL] [Abstract][Full Text] [Related]
10. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.
Yakatan GJ; Maness DD; Scholler J; Johnston JT; Novick WJ; Doluisio JT
Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):465-82. PubMed ID: 109903
[TBL] [Abstract][Full Text] [Related]
11. Protein binding and bilirubin displacing properties of bumetanide and furosemide.
Turmen T; Thom P; Louridas AT; LeMorvan P; Aranda JV
J Clin Pharmacol; 1982; 22(11-12):551-6. PubMed ID: 7161408
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of furosemide in geriatric patients.
Mühlberg W; Platt D; Neubig E
Arch Gerontol Geriatr; 1986 Oct; 5(3):249-63. PubMed ID: 3800492
[TBL] [Abstract][Full Text] [Related]
13. Saturable first-pass kinetics, plasma protein binding, and the furosemide intricacies.
Keller F
Clin Nephrol; 1995 Jan; 43 Suppl 1():S24-6. PubMed ID: 7781201
[TBL] [Abstract][Full Text] [Related]
14. Displacement of bilirubin from human albumin by three diuretics.
Wennberg RP; Rasmussen F; Ahlfors CE
J Pediatr; 1977 Apr; 90(4):647-50. PubMed ID: 839388
[TBL] [Abstract][Full Text] [Related]
15. Disposition of furosemide in functionally hepatectomized dogs.
Verbeeck RK; Gerkens JF; Wilkinson GR; Branch RA
J Pharmacol Exp Ther; 1981 Mar; 216(3):479-83. PubMed ID: 7205627
[TBL] [Abstract][Full Text] [Related]
16. [Furosemide--pharmacokinetics in geriatric patients with multimorbidity].
Neubig E; Mühlberg W; Platt D
Z Gerontol; 1984; 17(5):251-60. PubMed ID: 6523981
[TBL] [Abstract][Full Text] [Related]
17. Furosemide kinetics and dynamics in patients with cirrhosis.
Villeneuve JP; Verbeeck RK; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1986 Jul; 40(1):14-20. PubMed ID: 3720175
[TBL] [Abstract][Full Text] [Related]
18. Effects of probenecid on furosemide kinetics and natriuresis in man.
Honari J; Blair AD; Cutler RE
Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent pharmacokinetics of furosemide in the rat.
Hammarlund MM; Paalzow LK
Biopharm Drug Dispos; 1982; 3(4):345-59. PubMed ID: 7159689
[TBL] [Abstract][Full Text] [Related]
20. Quantitative contribution of endogenous compounds and hypoalbuminemia in reducing the binding of furosemide in the plasma of newborn infants.
Viani A; Pacifici GM
Dev Pharmacol Ther; 1992; 18(1-2):39-43. PubMed ID: 1483361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
